A study published in JAMA Surgery involving nearly 500,000 surgeries among U.S. veterans found that patients taking SGLT2 ...

The global Interleukin Inhibitors Market is estimated to be valued at USD 36.78 Bn in 2025 and is expected to reach USD 85.51 ...

Rising demand for eco-friendly detergents and health supplements drives glucaric acid market growth amid increasing consumer wellness awareness globally.Austin, June 26, 2025 (GLOBE NEWSWIRE) -- The ...

In the wake of Andrea's short tenure over the open Atlantic, tropical trouble can soon occur closer to home, with a risk of ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

The SEQUOIA arm D study demonstrates promising outcomes for treatment-naive patients with CLL, including high-risk patients.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

GLP-1 receptor agonists may increase the risk of several autoimmune diseases in adults with type 2 diabetes, according to ...

JAK inhibitors commonly induce acne in IBD patients, with upadacitinib posing the highest risk. Middle-aged adults and those ...